ID26137A - Komposisi farmasi baru dari uridin trifosfat - Google Patents

Komposisi farmasi baru dari uridin trifosfat

Info

Publication number
ID26137A
ID26137A IDW20001428A ID20001428A ID26137A ID 26137 A ID26137 A ID 26137A ID W20001428 A IDW20001428 A ID W20001428A ID 20001428 A ID20001428 A ID 20001428A ID 26137 A ID26137 A ID 26137A
Authority
ID
Indonesia
Prior art keywords
trifosphate
uridin
pharmaceutical composition
new pharmaceutical
new
Prior art date
Application number
IDW20001428A
Other languages
English (en)
Inventor
Karol K Lacroix
Christy L Shaffer
Karla M Jacobus
Janet L Rideout
David J Drutz
Richard M Evans
Pendergast William
Original Assignee
Inspire Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inspire Pharmaceuticals Inc filed Critical Inspire Pharmaceuticals Inc
Publication of ID26137A publication Critical patent/ID26137A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IDW20001428A 1997-12-23 1998-12-23 Komposisi farmasi baru dari uridin trifosfat ID26137A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/996,740 US5968913A (en) 1996-07-03 1997-12-23 Pharmaceutical compositions of uridine triphosphate

Publications (1)

Publication Number Publication Date
ID26137A true ID26137A (id) 2000-11-23

Family

ID=25543248

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001428A ID26137A (id) 1997-12-23 1998-12-23 Komposisi farmasi baru dari uridin trifosfat

Country Status (17)

Country Link
US (1) US5968913A (id)
EP (1) EP1041969B1 (id)
JP (1) JP2001526208A (id)
KR (1) KR20010033310A (id)
CN (1) CN1143672C (id)
AR (1) AR014176A1 (id)
AT (1) ATE235225T1 (id)
AU (1) AU747350B2 (id)
BR (1) BR9814426A (id)
CA (1) CA2316018A1 (id)
DE (1) DE69812708T2 (id)
ID (1) ID26137A (id)
IL (1) IL136895A0 (id)
NO (1) NO20003246L (id)
NZ (1) NZ505821A (id)
WO (1) WO1999032085A2 (id)
ZA (1) ZA9811833B (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
ATE261982T1 (de) 1997-07-25 2004-04-15 Inspire Pharmaceuticals Inc Salze von di(uridine 5'-tetraphosphate), verfahren zur herstellung und verwendungen davon
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6327215B1 (en) * 2000-09-28 2001-12-04 Vanguard International Semiconductor Corporation Local bit switch decode circuit and method
WO2003000056A1 (en) 2001-06-25 2003-01-03 Inspire Pharmaceuticals, Inc. Joint lubrication with p2y purinergic receptor agonists
BR0213897A (pt) * 2001-11-06 2006-05-23 Inspire Pharmaceuticals Inc uso de uma formulação farmacêutica que compreende um receptor de nucleotìdeo na preparação de medicamento
CN1700894A (zh) * 2002-10-18 2005-11-23 莫利化学医药公司 使用羊毛硫抗生素治疗干眼病的方法
US7326683B2 (en) * 2004-05-06 2008-02-05 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US20120077778A1 (en) * 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2556832B1 (en) 2011-08-12 2017-07-19 Universitätsklinikum Freiburg Uridine and uridine analogues for use in the treatment of chronic obstructive pulmonary disease
US9034442B2 (en) * 2012-11-30 2015-05-19 Corning Incorporated Strengthened borosilicate glass containers with improved damage tolerance
US10117806B2 (en) * 2012-11-30 2018-11-06 Corning Incorporated Strengthened glass containers resistant to delamination and damage

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB916309A (en) * 1959-12-14 1963-01-23 Ile Auguil Soc Civ Improvements in and relating to new therapeutic preparation for use as a muscular and nervous stimulant
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
US5164740A (en) * 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
FR2677250B1 (fr) * 1991-06-05 1995-01-20 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
EP0517573A1 (fr) * 1991-06-05 1992-12-09 Synthelabo Compositions pharmaceutiques pour le traitement des affections des voies respiratoires
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
JP2849647B2 (ja) * 1991-12-04 1999-01-20 ザ テクノロジー パートナーシップ ピーエルシー 流体の小水滴製造装置及びその方法
US5547131A (en) * 1992-12-04 1996-08-20 Bespak Plc Dispensing device with spray nozzle and driven piston
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
CN1229114C (zh) * 1996-03-27 2005-11-30 印斯拜尔药品股份有限公司 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法
US5789391A (en) * 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US5962432A (en) * 1996-07-03 1999-10-05 Inspire Pharmaceuticals, Inc. Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
US5763447C1 (en) * 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds

Also Published As

Publication number Publication date
KR20010033310A (ko) 2001-04-25
EP1041969B1 (en) 2003-03-26
ATE235225T1 (de) 2003-04-15
CN1284861A (zh) 2001-02-21
DE69812708D1 (de) 2003-04-30
AR014176A1 (es) 2001-02-07
CA2316018A1 (en) 1999-07-01
NO20003246L (no) 2000-08-23
BR9814426A (pt) 2001-10-23
AU747350B2 (en) 2002-05-16
IL136895A0 (en) 2001-06-14
WO1999032085A2 (en) 1999-07-01
NO20003246D0 (no) 2000-06-21
JP2001526208A (ja) 2001-12-18
CN1143672C (zh) 2004-03-31
ZA9811833B (en) 1999-07-20
WO1999032085A3 (en) 1999-09-02
NZ505821A (en) 2002-09-27
US5968913A (en) 1999-10-19
AU2092299A (en) 1999-07-12
DE69812708T2 (de) 2004-01-29
EP1041969A2 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
ID29306A (id) Bentuk baru s-omeprazola
PT1066027E (pt) Composicao farmaceutica de topiramato
ID16420A (id) Komposisi farmasi baru dengan efek anastesia
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
IS5245A (is) Lyfjablanda úr ómeprasól
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
ID29994A (id) Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
ID22973A (id) Komposisi farmasi dari pemberian oral dari turunan n-piperidino-3-pirazolkarboksamida, garam-garam dan solvatnya
ID27040A (id) Bentuk sediaan dengan pelepasan berpulsa dari bahan farmasi oral
PT907364E (pt) Composicao farmaceutica de libertacao sustida
ID15880A (id) Bentuk baru heteroaril oksazolidinon-oksazolidinon
IS5665A (is) Lyfjafræðileg þrýstiúða samsetning
DK0920302T3 (da) Farmaceutisk aerosolsammensætning
ID27996A (id) Polimorf dari suatu bahan farmasi
ID21525A (id) Komposisi bedak baru
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
ID24716A (id) Formulasi baru
ID29294A (id) Komposisi farmasi
FI973229A (fi) Uusi farmaseuttinen koostumus
MA26531A1 (fr) Composition pharmaceutique
ID25857A (id) Komposisi farmasi
ID23885A (id) Bentuk-bentuk polimorf baru dari cypamfylline
ID27096A (id) Komposisi farmasi yang baru
ID18698A (id) Komposisi farmasi